SCHEDULE 13D

Company

Arcutis Biotherapeutics, Inc.

Filed

February 7, 2020

Accession Number

0001193125-20-028142

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →